Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT05497453
A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 19, 2022
Completion: Nov 21, 2024